Gene editing and gene therapy can delete disease-causing genes in order to treat specific diseases. But the skill to control unwanted genes is a point of concern, as it might cause severe side effects. A research team from Cardiff University and the University of Bath have devised a switch to control protein expression in mouse embryos, which could be used in human gene therapies in future.
Ddu is an advanced global e-business trading platform for cross-border medical commerce. We devote our efforts to breaking the industry barriers to finding clients, establishing cross-border trade and building communication channels. We also assist suppliers and buyers from all over the world to solidify international business and provide complete solutions.
Onitor Track is an advanced biometric, data-driven program which aids in weight loss. Onitor Track combines a personalized weight loss and nutrition program with a dual-positioned wearable via an app.
The research team claimed that the effectiveness of drugs depends on the time of administration on a personalized level. Their goal was to identify the biomarkers in blood to characterize the ‘internal time’ of an individual.
This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
In a major breakthrough in the medical field, one of the world’s most dreadful viruses could possibly treat deadly brain tumors (glioblastoma). The survival chance turned out to be better than expected especially for patients who were administered the genetically modified poliovirus.
Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
Johnson & Johnson has once again won in its appeals campaign against talcum powder verdicts. Last year, the company had secured two reversals. In this year, the Missouri Court of Appeals reversed another verdict in Gloria Ristesund’s case worth $55 million, where the court lacked jurisdiction.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.